Literature DB >> 1654169

Flunarizine inhibits a high-threshold inactivating calcium channel (N-type) in isolated hippocampal neurons.

J Tytgat1, P J Pauwels, J Vereecke, E Carmeliet.   

Abstract

The action of flunarizine on the high-threshold inactivating calcium channel (N-type) in hippocampal neurons of the rat was investigated using the whole-cell voltage clamp technique. Flunarizine reduced the currents at all test potentials, without shifting the peak of the current-voltage relationship along the voltage-axis. The drug did not affect the activation curve, but drastically decreased the slope conductance in the linear region of the current-voltage relationship. Block of the current by flunarizine occurred in a use-dependent way. Flunarizine was without effect when applied intracellulary, and the onset of action, when applied extracellularly, was slow (range of minutes). The Kd for the block by flunarizine obtained after 6 repetitive depolarizations at 0.2 Hz (pulse duration 150 ms) from -90 mV to 0 mV was 0.8 microM. In conclusion, we present electrophysiological evidence that flunarizine blocks the high-threshold inactivating Ca channel of hippocampal neurons of the rat. We discuss the possibility that flunarizine might inhibit neuronal transmitter release by means of this effect.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654169     DOI: 10.1016/0006-8993(91)90606-v

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Changes of intracellular free calcium following mechanical injury in a spinal cord slice preparation.

Authors:  L Leybaert; A de Hemptinne
Journal:  Exp Brain Res       Date:  1996-12       Impact factor: 1.972

2.  Differential inhibition of T-type calcium channels by neuroleptics.

Authors:  Celia M Santi; Francisco S Cayabyab; Kathy G Sutton; John E McRory; Janette Mezeyova; Kevin S Hamming; David Parker; Anthony Stea; Terrance P Snutch
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

3.  Robust anti-arrhythmic efficacy of verapamil and flunarizine against dofetilide-induced TdP arrhythmias is based upon a shared and a different mode of action.

Authors:  A Oros; M J Houtman; P Neco; A M Gomez; S Rajamani; P Oosterhoff; N J Attevelt; J D Beekman; M A G van der Heyden; L Ver Donck; L Belardinelli; S Richard; G Antoons; M A Vos
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

4.  Effects of flunarizine on induced calcium transients as measured in fura-2-loaded neurons of the rat dorsal root ganglion.

Authors:  L Leybaert; G De Ley; A de Hemptinne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

5.  Effects of flunarizine on spontaneous synaptic currents in rat neocortex.

Authors:  P T Golumbek; J M Rho; W J Spain; J F M van Brederode
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-01       Impact factor: 3.000

Review 6.  Cardioselectivity of calcium antagonists.

Authors:  T Godfraind
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

7.  Blockade by sigma site ligands of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones.

Authors:  J Church; E J Fletcher
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

8.  Interstitial and tissue cations and electrical potential after experimental spinal cord injury.

Authors:  L Leybaert; G De Ley
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

9.  Termination of a tachyarrhythmia by flunarizine is not a specific marker for a triggered mechanism.

Authors:  Sergey A Vitebskiy; Celeen M Khrestian; Albert L Waldo
Journal:  Heart Rhythm       Date:  2007-08-24       Impact factor: 6.343

10.  Blockade by ifenprodil of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones: comparison with N-methyl-D-aspartate receptor antagonist actions.

Authors:  J Church; E J Fletcher; K Baxter; J F MacDonald
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.